PL3597648T3 - METODA WYTWARZANIA 3,6-DIPODSTAWIONEJ POCHODNEJ IMIDAZO[1, 2-b]PIRYDAZYNY - Google Patents

METODA WYTWARZANIA 3,6-DIPODSTAWIONEJ POCHODNEJ IMIDAZO[1, 2-b]PIRYDAZYNY

Info

Publication number
PL3597648T3
PL3597648T3 PL18766623.5T PL18766623T PL3597648T3 PL 3597648 T3 PL3597648 T3 PL 3597648T3 PL 18766623 T PL18766623 T PL 18766623T PL 3597648 T3 PL3597648 T3 PL 3597648T3
Authority
PL
Poland
Prior art keywords
disububutted
imidazo
preparation
pyridazine derivative
pyridazine
Prior art date
Application number
PL18766623.5T
Other languages
English (en)
Inventor
Ryoji KOIKE
Yoshifumi HACHISU
Takafumi KITAWAKI
Shohei SHIRAISHI
Original Assignee
Daiichi Sankyo Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Company, Limited filed Critical Daiichi Sankyo Company, Limited
Publication of PL3597648T3 publication Critical patent/PL3597648T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/14—Adipic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00—Other general methods
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL18766623.5T 2017-03-14 2018-03-13 METODA WYTWARZANIA 3,6-DIPODSTAWIONEJ POCHODNEJ IMIDAZO[1, 2-b]PIRYDAZYNY PL3597648T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017049138 2017-03-14
PCT/JP2018/009596 WO2018168815A1 (ja) 2017-03-14 2018-03-13 ３，６－ジ置換イミダゾ［１，２－ｂ］ピリダジン誘導体の製造方法

Publications (1)

Publication Number Publication Date
PL3597648T3 true PL3597648T3 (pl) 2023-07-24

Family

ID=63523451

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18766623.5T PL3597648T3 (pl) 2017-03-14 2018-03-13 METODA WYTWARZANIA 3,6-DIPODSTAWIONEJ POCHODNEJ IMIDAZO[1, 2-b]PIRYDAZYNY

Country Status (13)

Country Link
US (3) US11028091B2 (pl)
EP (2) EP3597648B1 (pl)
JP (4) JP7082608B2 (pl)
CN (2) CN114773351A (pl)
AU (1) AU2018234027B2 (pl)
CA (1) CA3055504A1 (pl)
ES (1) ES2947326T3 (pl)
HR (1) HRP20230764T1 (pl)
HU (1) HUE063830T2 (pl)
PL (1) PL3597648T3 (pl)
RS (1) RS64354B1 (pl)
SM (1) SMT202300269T1 (pl)
WO (1) WO2018168815A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2947326T3 (es) * 2017-03-14 2023-08-04 Daiichi Sankyo Co Ltd Procedimiento de producción de un derivado de imidazo[1,2-b]piridazina 3,6-disubstituido
CA3223035A1 (en) * 2021-07-01 2023-01-05 Anheart Therapeutics (Hangzhou) Co., Ltd. Crystalline forms of 3-{4-[(2r)-2-aminopropoxy]phenyl}-n-[(1r)- 1-(3-fluorophenyl) ethyl]imidazo[1,2-b]pyridazin-6-amine and salts thereof
JP2025515952A (ja) * 2022-05-18 2025-05-20 アンハート セラピューティクス（ハンチョウ）コーポレーション，リミテッド ３，６－二置換－イミダゾ［１，２－ｂ］ピリダジン化合物の製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60197640A (ja) * 1984-03-19 1985-10-07 Ihara Chem Ind Co Ltd ハロゲン化ニトロベンゼン類の製造方法
JPS61205220A (ja) * 1985-03-08 1986-09-11 Rikagaku Kenkyusho 一級アルコ−ル類の選択的フツ素化方法
JP3551493B2 (ja) * 1994-10-21 2004-08-04 三菱化学株式会社 新規ビスオキサゾリン化合物
JP2002193914A (ja) * 2000-05-24 2002-07-10 Nissan Chem Ind Ltd ニトリル化合物およびその製造方法
AU2001260607A1 (en) * 2000-05-24 2001-12-03 Nissan Chemical Industries Ltd. Nitrile compounds and process for their preparation
FR2918061B1 (fr) * 2007-06-28 2010-10-22 Sanofi Aventis Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique.
FR2934994B1 (fr) * 2008-08-12 2010-09-17 Sanofi Aventis Derives de 2-alkyl-6cycloamino-3-(pyridin-4-yl)imidaz°1,2-b! pyridazine, leur preparation et leur application en therapeutique
MX347917B (es) * 2012-03-09 2017-05-17 Lexicon Pharmaceuticals Inc Compuestos a base de imidazo[1,2-b]piridazina, composiciones que los comprenden, y metodos para su uso.
TWI585088B (zh) 2012-06-04 2017-06-01 第一三共股份有限公司 作爲激酶抑制劑之咪唑并［１，２－ｂ］嗒衍生物
CN105431148A (zh) * 2013-03-07 2016-03-23 加利菲亚生物公司 混合谱系激酶抑制剂及治疗方法
US9193736B2 (en) * 2013-06-11 2015-11-24 Janssen Pharmaceutica, Nv PDE 10a inhibitors for the treatment of type II diabetes
ES2947326T3 (es) 2017-03-14 2023-08-04 Daiichi Sankyo Co Ltd Procedimiento de producción de un derivado de imidazo[1,2-b]piridazina 3,6-disubstituido
JP7648372B2 (ja) * 2020-11-30 2025-03-18 株式会社ファンケル クロロフィル含有食品用緑色退色抑制剤

Also Published As

Publication number Publication date
JP7082608B2 (ja) 2022-06-08
JP7384963B2 (ja) 2023-11-21
JPWO2018168815A1 (ja) 2020-04-23
ES2947326T3 (es) 2023-08-04
SMT202300269T1 (it) 2023-09-06
EP3597648A1 (en) 2020-01-22
CA3055504A1 (en) 2018-09-20
JP2023171735A (ja) 2023-12-05
US20230227459A1 (en) 2023-07-20
EP3597648A4 (en) 2020-10-14
CN110418792B (zh) 2022-07-05
JP2022105746A (ja) 2022-07-14
AU2018234027B2 (en) 2021-12-09
RS64354B1 (sr) 2023-08-31
HUE063830T2 (hu) 2024-02-28
WO2018168815A1 (ja) 2018-09-20
EP3597648C0 (en) 2023-06-07
US20200062765A1 (en) 2020-02-27
CN110418792A (zh) 2019-11-05
AU2018234027A1 (en) 2019-10-31
US11028091B2 (en) 2021-06-08
CN114773351A (zh) 2022-07-22
US11667642B2 (en) 2023-06-06
HRP20230764T1 (hr) 2023-10-13
JP2025123513A (ja) 2025-08-22
EP4101853A1 (en) 2022-12-14
US20210171532A1 (en) 2021-06-10
EP3597648B1 (en) 2023-06-07

Similar Documents

Publication Publication Date Title
ZA201905456B (en) Pyrrolo[1,2-b]pyridazine derivatives
HUE051067T2 (hu) N-szulfonilezett pirazolo[3,4-b]piridin-6-karboxamidok és alkalmazási módszereik
EP3452481A4 (en) IMIDAZO [1,2-B] SUBSTITUTED PYRIDAZINES, IMIDAZO [1,5-B] SUBSTITUTED PYRIDAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL CONDITIONS
ZA201900236B (en) Imidazo[1,2-a]pyridine derivatives, methods for preparing the same and use thereof
LT3555097T (lt) Imidazo[4,5-d]pirolo[2,3-b]piridino junginiai kaip janus kinazės inhibitoriai
IL255488B (en) Pyrido[4,3-di]pyrimidine derivative and its pharmaceutically acceptable salt
DK3478681T3 (da) 1h-pyrazolo[4,3-b]pyridiner som pde1-inhibitorer
EP3321271A4 (en) PROCESS FOR THE PRODUCTION OF THE 7H-PYROLLO [2,3-D] PYRIMIDINE DERIVATIVE AND THE CORRESPONDING INTERMEDIATE
EP3380475A4 (en) OCTAHYDROPYRROLO [3,4-C
LT3820872T (lt) Pirolo[1,2-b]piridazino dariniai
EP3102036A4 (en) 3-substituted carbonyl-naphtho[2,3-b]furane derivative or pharmaceutically acceptable salt thereof
EP3508487A4 (en) PYRAZOLO [1,5-A] PYRIMIDINE COMPOUND
DK3840832T3 (da) Imidazo[1,2-b]pyridaziner som trk-inhibitorer
EP3551630A4 (en) IMIDAZO [1,5-A] PYRAZINE DERIVATIVES AS PI3KDELTA INHIBITORS
IL258070A (en) Cyclic ether history of pyrazolo[5,1-a]pyrimidine-3-carboxamide
IL269215A (en) Disubstituted imidazole[4,5-C]quinoline derivatives
HUE057202T2 (hu) Kombinációs kezelések 1H-pirazolo[4,3-b]piridinek alkalmazásával
PL3597648T3 (pl) METODA WYTWARZANIA 3,6-DIPODSTAWIONEJ POCHODNEJ IMIDAZO[1, 2-b]PIRYDAZYNY
EP3190111A4 (en) Pyrazolo[3,4-c]pyridine derivatives
EP3640253A4 (en) 6H-THIEN [2,3-E] [1,2,4] TRIAZOLE [3,4-C] [1,2,4] TRIAZEPINE DERIVATIVE